Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.

Vadivelan AA, Nakano T, Everitt MD

Open source

DOI
10.1002/1545-5017.70555
Published
2026 Oct
Container
Pediatric blood & cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/1545-5017.70555,
  title = {Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.},
  author = {Vadivelan AA and Nakano T and Everitt MD},
  year = {2026},
  journal = {Pediatric blood \& cancer},
  doi = {10.1002/1545-5017.70555},
  url = {https://doi.org/10.1002/1545-5017.70555}
}

RIS

TY  - JOUR
TI  - Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.
AU  - Vadivelan AA
AU  - Nakano T
AU  - Everitt MD
PY  - 2026
JO  - Pediatric blood & cancer
DO  - 10.1002/1545-5017.70555
UR  - https://doi.org/10.1002/1545-5017.70555
ER  - 

APA

AA, V., T, N., & MD, E. (2026). Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70555

Source records